Home > Research


Research news

Erstmaliger Einsatz genmodifizierter natürlicher Killerzellen bei Hirntumorpatient >>

Research news

Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia >>

Research news

Successes and challenges of leukaemia treatment using CAR-T cells – where are we now? >>

Research news

Innovative research results of LOEWE-CGT in the field of gene therapy >>

Specific Topics

Specific Topics of LOEWE-CGT include reprogramming, iPS, homing of stem cells, stem cell transplantation, cell- and gene-therapy >>


The platforms of LOEWE-CGT include a GMP-Core Facility in cooperation with the Institute for Transfusion Medicine and Immunohaematology in Frankfurt, as well as vector development and quality assurance >>

Research areas

Six different research areas are essentiell for the LOEWE-CGT: 1. regenerative medicine, 2. stem cell transplantation and immunotherapy, 3.stem cell therapy, 4. cardiovascular disease, 5. signal transduction and stem cell biology, 6. risk analysis >>

Interdisciplinary Networks

The development of novel therapeutic procedures requires the interaction of different disciplines and a good developed infrastructure of a broad spectrum of facilities. >>

Logo: Paul-Ehrlich-Institut Logo: Georg Speyer Haus Logo: Goethe Universität Logo: Max-Planck-Institut Logo: DRK Blutspendedienst